You are here

  • Home
  • Archive
  • Volume 8, Issue 1
  • Optimized combinatorial pMHC class II multimer labeling for precision immune monitoring of tumor-specific CD4 T cells in patients

Article info

Article menu

Download PDFPDF

XML
Clinical/translational cancer immunotherapy
Original research
Optimized combinatorial pMHC class II multimer labeling for precision immune monitoring of tumor-specific CD4 T cells in patients

Authors

  • Georg Alexander Rockinger Department of Oncology UNIL CHUV, University of Lausanne, Epalinges, Switzerland Ludwig Institute for Cancer Research, Lausanne Branch of Immunology, Epalinges, Switzerland PubMed articlesGoogle scholar articles
  • Philippe Guillaume Department of Oncology UNIL CHUV, University of Lausanne, Epalinges, Switzerland Ludwig Institute for Cancer Research, Lausanne Branch of Immunology, Epalinges, Switzerland PubMed articlesGoogle scholar articles
  • Amélie Cachot Department of Oncology UNIL CHUV, University of Lausanne, Epalinges, Switzerland Ludwig Institute for Cancer Research, Lausanne Branch of Immunology, Epalinges, Switzerland PubMed articlesGoogle scholar articles
  • Margaux Saillard Department of Oncology UNIL CHUV, University of Lausanne, Epalinges, Switzerland Ludwig Institute for Cancer Research, Lausanne Branch of Immunology, Epalinges, Switzerland PubMed articlesGoogle scholar articles
  • Daniel E Speiser Department of Oncology UNIL CHUV, University of Lausanne, Epalinges, Switzerland PubMed articlesGoogle scholar articles
  • Georges Coukos Department of Oncology UNIL CHUV, University of Lausanne, Epalinges, Switzerland Ludwig Institute for Cancer Research, Lausanne Branch of Immunology, Epalinges, Switzerland PubMed articlesGoogle scholar articles
  • Alexandre Harari Department of Oncology UNIL CHUV, University of Lausanne, Epalinges, Switzerland Ludwig Institute for Cancer Research, Lausanne Branch of Immunology, Epalinges, Switzerland PubMed articlesGoogle scholar articles
  • Pedro J Romero Department of Oncology UNIL CHUV, University of Lausanne, Epalinges, Switzerland PubMed articlesGoogle scholar articles
  • Julien Schmidt Department of Oncology UNIL CHUV, University of Lausanne, Epalinges, Switzerland Ludwig Institute for Cancer Research, Lausanne Branch of Immunology, Epalinges, Switzerland PubMed articlesGoogle scholar articles
  • Camilla Jandus Department of Oncology UNIL CHUV, University of Lausanne, Epalinges, Switzerland Ludwig Institute for Cancer Research, Lausanne Branch of Immunology, Epalinges, Switzerland PubMed articlesGoogle scholar articles

Citation

Rockinger GA, Guillaume P, Cachot A, et al
Optimized combinatorial pMHC class II multimer labeling for precision immune monitoring of tumor-specific CD4 T cells in patients
Journal for ImmunoTherapy of Cancer 2020;8:e000435. doi: 10.1136/jitc-2019-000435
Online issue publication 
January 11, 2022

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© Author(s) (or their employer(s)) 2020. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. http://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See http://creativecommons.org/licenses/by-nc/4.0/.